Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

CAPS Rating: 1 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

Recs

0
Player Avatar mjan706 (60.17) Submitted: 9/22/2008 1:44:10 AM : Outperform Start Price: $22.84 REGN Score: +469.90

An Icahn portfolio stock.

Featured Broker Partners


Advertisement